TY  - CHAP
M1  - Book, Section
TI  - Early Esophageal Cancer: Endoscopic Treatment Options
A1  - Hoppo, Toshitaka
A1  - Jobe, Blair A.
A2  - Morita, Shane Y.
A2  - Balch, Charles M.
A2  - Klimberg, V. Suzanne
A2  - Pawlik, Timothy M.
A2  - Posner, Mitchell C.
A2  - Tanabe, Kenneth K.
PY  - 2018
T2  - Textbook of Complex General Surgical Oncology
AB  - Esophageal  resection  (esophagectomy)  has  been  a  standard  surgical  treatment  option  for  any  resectable  esophageal  cancer.  Esophagectomy  is  one  of  the  most  complex,  invasive  procedures  in  the  upper  gastrointestinal  tract,  and  is  associated  with  high  mortality  and  morbidity  even  with  the  recent  refinement  of  surgical  techniques  and  perioperative  care.1,2  Accumulating  data  have  suggested  that  the  probability  of  lymph  node  involvement  in  patients  with  early  esophageal  cancer  (T1a  intramucosal  cancer)  is  unlikely  (<2%),  and  esophagectomy  may  be  unnecessarily  invasive  for  patients  with  early  esophageal  cancer.3-5  With  the  introduction  of  endoscopic  surveillance  program  and  advancement  in  optic  technology,  patients  with  early  esophageal  cancer  have  been  increasingly  encountered,  and  interest  in  esophageal-preserving  endoscopic  treatments  has  grown.  Esophageal-preserving  treatments  include  any  endoluminal  procedure  that  is  performed  in  an  attempt  to  completely  eradicate  disease  while  preserving  the  anatomical  structure  of  esophagus.  There  are  primarily  two  esophageal-preserving  treatments:  endoscopic  ablation  (radiofrequency  ablation  and  cryotherapy)  and  endoscopic  resection  (endoscopic  mucosal  resection  and  endoscopic  submucosal  dissection).  However,  the  concept  of  esophageal-preserving  treatments  has  caused  confusion  in  the  decision-making  among  health  care  providers.  Patients  with  early  esophageal  cancer  have  a  chance  for  cure,  and  it  is  therefore  extremely  important  to  determine  if  esophageal-preserving  treatments  are  adequate  to  achieve  complete  cure,  that  is,  minimizing  residual  or  recurrent  disease.  In  this  chapter,  we  focus  on  esophageal-preserving  treatments  for  patients  with  early  esophageal  cancer.  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/04/18
UR  - accesssurgery.mhmedical.com/content.aspx?aid=1145761004
ER  -